Tom Lanz

7PUBLICATIONS
15CO-AUTHORS
Peripheral nervous systemNeurology and neuromuscular diseasesGene and molecular therapyGene expression (incl. microarray and other genome-wide approaches)Computational neuroscience (incl. mathematical neuroscience and theoretical neuroscience)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Jul 24, 2026
Regulatory endorsement for the application of α-synuclein seed amplification assay as a susceptibility and risk biomarker for clinical trials targeting synucleinopathies.

|Oct 29, 2025
Correction: Longitudinal evaluation of serum neurofilament light levels in normal healthy volunteers: defining a threshold of concern.

Thomas A Lanz, Klemens Ruprecht, Christopher J Somps

|Jul 15, 2025
Longitudinal evaluation of serum neurofilament light levels in normal healthy volunteers: defining a threshold of concern.

Thomas A Lanz, Klemens Ruprecht, Christopher J Somps

|Feb 13, 2025
Generation of cynomolgus monkey capsid-specific positive control cells for IFNγ ELISpot assays for adeno-associated gene therapy applications.

Sandra Casinghino, Karrie Tartaro, Jessica Anderson

|Feb 20, 2021
Schizophrenia-associated SLC39A8 polymorphism is a loss-of-function allele altering glutamate receptor and innate immune signaling.

Wei Chou Tseng, Veronica Reinhart, Thomas A Lanz

|Jun 05, 2020
GluN2D-mediated excitatory drive onto medial prefrontal cortical PV+ fast-spiking inhibitory interneurons.

Jonathan Garst-Orozco, Ruchi Malik, Thomas A Lanz

Pageof 2

Frequent Collaborators

2 joint publications

Patricio O'Donnell

1 joint publications

Zhicheng Shao

1 joint publications

Joseph T Coyle

1 joint publications

Daniel R Weinberger